Ausgabe 1/2014
Inhalt (14 Artikel)
Focal 18F-FDG uptake in bone marrow on PET/CT in a patient with JAK2 mutation without overt myeloproliferative neoplasm
Akihito Fujimi, Yuji Kanisawa, Shinya Minami, Yusuke Kamihara, Sari Iwasaki
Expression of different functional isoforms in haematopoiesis
Godfrey Grech, Joel Pollacco, Mark Portelli, Keith Sacco, Shawn Baldacchino, Justine Grixti, Christian Saliba
Hepcidin production in response to iron is controlled by monocyte-derived humoral factors
Yusuke Sasaki, Yasushi Shimonaka, Katsuya Ikuta, Takaaki Hosoki, Katsunori Sasaki, Yoshihiro Torimoto, Hirotaka Kanada, Yoshiyuki Moriguchi, Yutaka Kohgo
Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ–TIF2 fusion
Haruko Shima, Kazutsune Yamagata, Yukiko Aikawa, Mika Shino, Haruhiko Koseki, Hiroyuki Shimada, Issay Kitabayashi
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients
Margarida Coucelo, Gonçalo Caetano, Teresa Sevivas, Susana Almeida Santos, Teresa Fidalgo, Celeste Bento, Manuela Fortuna, Marta Duarte, Cristina Menezes, M. Letícia Ribeiro
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia
Takashi Kumagai, Eri Matsuki, Koiti Inokuchi, Kazuteru Ohashi, Atsushi Shinagawa, Jin Takeuchi, Chikashi Yoshida, Shinichiro Okamoto, Hisashi Wakita, Yasuji Kozai, Yukari Shirasugi, Shin Fujisawa, Osamu Iwase, Shingo Yano, Kaichi Nishiwaki, Koji Oba, Junichi Sakamoto, Hisashi Sakamaki
Distribution of serum erythropoietin levels in lower risk myelodysplastic syndrome cases with anemia
Kumi Nakazaki, Yasuhito Nannya, Mineo Kurokawa
A role for activator of G-protein signaling 3 (AGS3) in multiple myeloma
Shan Shao, Xianting Huang, Yuchan Wang, Song He, Xiaohong Xu, Xinghua Zhu, Xiaojing Yang, Zongmei Ding, Li Yao, Yuejiao Huang, Chun Wang
High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis
Lin Gui, Yuan-kai Shi, Xiao-hui He, Ying-heng Lei, Hong-zhi Zhang, Xiao-hong Han, Sheng-yu Zhou, Peng Liu, Jiang-liang Yang, Mei Dong, Chang-gong Zhang, Sheng Yang, Yan Qin
Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression
Yan Li, Maimaitili Yimamu, Xiaomin Wang, Xiaoyan Zhang, Min Mao, Ling Fu, Aihemaitijiang Aisimitula, Yuling Nie, Qin Huang
Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation
Weiyi Xu, Baode Chen, Xiangmin Tong
Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity
Lars Harbaum, Andreas Marx, Eray Goekkurt, Philippe Schafhausen, Djordje Atanackovic
Significant improvement following combination treatment with mefloquine and mirtazapine in a patient with progressive multifocal leukoencephalopathy after allogeneic peripheral blood stem cell transplantation
Hitoshi Yoshida, Kenji Ohshima, Jun Toda, Shinsuke Kusakabe, Hiroaki Masaie, Toshinari Yagi, Jun Ishikawa
Validation of a new proposed relapse risk score (CBC-score) for acute promyelocytic leukaemia
Giuseppina Loglisci, Clara Minotti, Alessandra Serrao, Matteo Molica, Laura Cicconi, Roberta Saracino, Massimo Breccia